Sleep Screening and Intervention for Adolescents With Type 1 Diabetes in a Clinical Diabetes Center
1 other identifier
interventional
50
1 country
1
Brief Summary
This study is evaluating an in-clinic sleep screening and intervention algorithm for youth with type 1 diabetes. This study will assess health care provider feasibility of completion of intervention and long term follow up for adolescents with T1D.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 23, 2026
CompletedFirst Submitted
Initial submission to the registry
February 27, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
March 27, 2026
March 1, 2026
9 months
February 27, 2026
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intervention Completion Rate
Assess the feasibility/rate of completion of sleep intervention discussion within the clinic session based on the percent of interventions completed for those who screened positive in the sleep screening.
Day 1
Study Arms (1)
Sleep Intervention
EXPERIMENTALAll adolescents enrolled will complete the sleep screening questionnaire
Interventions
Adolescents that screen positive for sleep concerns will receive targeted interventions based on their self-reported sleep barriers. These will be provided by the health care provider.
Eligibility Criteria
You may qualify if:
- Type 1 diabetes
- Receiving care at the Barbara Davis Center
- Using a continuous glucose monitor
You may not qualify if:
- Undiagnosed or untreated sleep disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Barbara Davis Center for Diabetes
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erin Cobry, MD
University Of Colorado, Barbara Davis Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2026
First Posted
March 27, 2026
Study Start
February 23, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03